Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for renal recovery in leptospirosis-associated acute renal failure
IRCT20190727044343N4Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetylcysteine in leptospirosis (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Acceleration of renal function improvement and Improvement in laboratory indicators of renal function. Started May 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
leptospirosis
Beyond the preview
Go deeper on IRCT20190727044343N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190727044343N4.